NasdaqGS:TXGLife Sciences
Is It Time To Reassess 10x Genomics (TXG) After Its 105% One Year Surge
If you are wondering whether 10x Genomics is priced attractively at its current level, this article walks through how its value stacks up using several common yardsticks.
The stock last closed at US$22.13, with returns of 15.3% over the past 7 days, 2.4% over 30 days, 33.2% year to date and 105.3% over 1 year, set against longer term returns of a 54.1% decline over 3 years and an 85.0% decline over 5 years.
Recent news flow around 10x Genomics has focused on its position in single cell and...